https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-adults-severe-hemophilia
0
0
6/29/23 at 10:00pm
Organization
FDA.gov
Author
Office of the Commissioner
FDA approves Roctavian, the first gene therapy for treatment of adults with severe hemophilia A.
Create an account
or login to join the discussion